Neousys Technology Inc. (TPEX:6922)
Taiwan · Delayed Price · Currency is TWD 180.50
-1.50 (-0.82%)
Aug 12, 2025, 1:30 PM CST
Ligand Pharmaceuticals Revenue
Neousys Technology had revenue of 419.17M TWD in the quarter ending June 30, 2025, with 18.95% growth. This brings the company's revenue in the last twelve months to 1.59B, up 31.13% year-over-year. In the year 2024, Neousys Technology had annual revenue of 1.45B with 37.02% growth.
Revenue (ttm)
1.59B
Revenue Growth
+31.13%
P/S Ratio
2.91
Revenue / Employee
12.15M
Employees
131
Market Cap
4.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.45B | 390.53M | 37.02% |
| Dec 31, 2023 | 1.05B | -227.10M | -17.72% |
| Dec 31, 2022 | 1.28B | 305.02M | 31.22% |
| Dec 31, 2021 | 976.89M | 261.43M | 36.54% |
| Dec 31, 2020 | 715.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 3,401.20B |
| Hon Hai Precision Industry | 7,179.94B |
| MediaTek | 573.54B |
| Delta Electronics | 469.36B |
| Quanta Computer | 1,637.49B |
| ASE Technology Holding | 621.27B |
| Wiwynn | 604.83B |
| Accton Technology | 170.52B |